Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters

Medical Physics

Volumn 33, Issue 9, 2006, Pages 3105-3115

  Carlson, David J ^a   Stewart, Robert D ^a   Semenenko, Vladimir A ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Hypoxia; Linear quadratic model; LQ; Oxygen; Radiosensitivity; Survival; TCP

Indexed keywords

CELLS; DIAGNOSIS; DISEASES; IONIZING RADIATION; MAMMALS; OXYGEN; RADIATION EFFECTS; RADIOTHERAPY; TUMORS;

ENHANCEMENT RATIOS; HYPOXIA; INTRINSIC RADIATION; LINEAR-QUADRATIC MODELS; OXYGEN CONCENTRATIONS; RADIOSENSITIVITY; RADIOSENSITIVITY PARAMETERS; SURVIVAL;

CYTOLOGY;

OXYGEN;

CELL STRAIN V 79; CELL SURVIVAL; CHO CELL; CONFERENCE PAPER; DATA ANALYSIS; DNA DAMAGE; ELECTRODE; HUMAN; HYPOXIA; IN VITRO STUDY; IONIZING RADIATION; MATHEMATICAL ANALYSIS; MODEL; NONHUMAN; ONCOLOGY; OXYGEN ENHANCEMENT RATIO; PARAMETERS OF MEASUREMENT AND ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION RESPONSE; RADIOSENSITIVITY; TECHNIQUE; TUMOR; UTERINE CERVIX CANCER;

MAMMALIA;

EID: 33748290305     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2229427     Document Type: Conference Paper

References (95)

1. C. C. Ling and X. A. Li, "Over the next decade the success of radiation treatment planning will be judged by the immediate biological response of tumor cells rather than by surrogate measures such as dose maximization and uniformity," Med. Phys. 32, 2189-2192 (2005).
2. J. F. Fowler, "The radiobiology of prostate cancer including new aspects of fractionated radiotherapy," Acta Oncol. 44, 265-276 (2005).
3. J. Z. Wang and X. A. Li, "Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose," Med. Phys. 30, 34-40 (2003).
4. D. J. Carlson, R. D. Stewart, X. A. Li, K. Jennings, J. Z. Wang, and M. Guerrero, "Comparison of in vitro and in vivo α/β ratios for prostate cancer," Phys. Med. Biol. 49, 4477-4491 (2004).
5. J. Z. Wang, X. A. Li, W. D'Souza, and R. D. Stewart, "Impacts of prolonged dose-delivery time on tumor control: A note of caution for IMRT," Int. J. Radiat. Oncol., Biol., Phys. 57, 543-552 (2003).
6. M. Nordsmark, M. Overgaard, and J. Overgaard, "Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck," Radiother. Oncol. 41, 31-39 (1996).
7. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher, and M. W. Dewhirst, "Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck," Int. J. Radiat. Oncol., Biol., Phys. 38, 285-289 (1997).
8. M. Höckel, K. Schlenger, S. Höckel, B. Aral, U. Schaffer, and P. Vaupel, "Tumor hypoxia in pelvic recurrences of cervical cancer," Int. J. Cancer 79, 365-369 (1998).
9. A. W. Fyles, M. Milosevic, R. Wong, M. C. Kavanagh, M. Pintilie, A. Sun, W. Chapman, W. Levin, L. Manchul, T. J. Keane, and R. P. Hill, "Oxygenation predicts radiation response and survival in patients with cervix cancer," Radiother. Oncol. 48, 149-156 (1998).
10. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix," Radiother. Oncol. 53, 99-104 (1999).
11. (a) K. Sundfør, H. Lyng, C. G. Tropé, and E. K. Rofstad, "Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pre-treatment tumor oxygenation and vascularization," Radiother. Oncol. 54, 101-107 (2000);
12. (b) Sundfør and Lyng (private communication).
13. 2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings," Urology 60, 634-639 (2002).
14. M. Höckel and P. Vaupel, "Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects," J. Natl. Cancer Inst. 93, 266-276 (2001).
15. M. Höckel and P. Vaupel, "Biological consequences of tumor hypoxia," Semin. Oncol. 28, 36-41 (2001).
16. M. Höckel, K. Schlenger, B. Aral, M. Mitze, U. Schaffer, and P. Vaupel, "Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix," Cancer Res. 56, 4509-4515 (1996).
17. K. Sundfør, H. Lyng, and E. K. Rofstad, "Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix," Br. J. Cancer 78, 822-827 (1998).
18. E. K. Rofstad, K. Sundfør, H. Lyng, and C. G. Trope, "Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis," Br. J. Cancer 83, 354-359 (2000).
19. P. Okunieff, M. Höckel, E. P. Dunphy, K. Schlenger, C. Knoop, and P. Vaupel, "Oxygen tension distributions are sufficient to explain the local response of human breast tumours treated with radiation alone," Int. J. Radiat. Oncol., Biol., Phys. 26, 631-636 (1993).
20. C. Parker, M. Milosevic, A. Toi, J. Sweet, T. Panzarella, R. Bristow, C. Catton, P. Catton, J. Crook, M. Gospodarowicz, M. McLean, P. Warde, and R. P. Hill, "Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 58, 750-757 (2004).
21. J. M. Brown and Q. T. Le, "Tumor hypoxia is important in radiotherapy, but how should we measure it?," Int. J. Radiat. Oncol., Biol., Phys. 54, 1299-1301 (2002).
22. 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy," J. Nucl. Med. 46, 253-260 (2005).
23. 60Cu-ATSM: Relationship to therapeutic response - a preliminary report," Int. J. Radiat. Oncol., Biol., Phys. 55, 1233-1238 (2003).
24. B. Gallez, C. Baudelet, and B. F. Jordan, "Assessment of tumor oxygenation by electron paramagnetic resonance: Principles and applications," NMR Biomed. 17, 240-262 (2004).
25. J. M. Star-Lack, E. Adalsteinsson, M. F. Adam, D. J. Terris, H. A. Pinto, J. M. Brown, and D. M. Spielman, "In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements," AJNR Am. J. Neuroradiol. 21, 183-193 (2000).
26. H. L. Janssen, K. M. Haustermans, D. Sprong, G. Blommestijn, I. Hofland, F. J. Hoebers, E. Blijweert, J. A. Raleigh, G. L. Semenza, M. A. Varia, A. J. Balm, M. L. van Velthuysen, P. Delaere, R. Sciot, and A. C. Begg, "HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors," Int. J. Radiat. Oncol., Biol., Phys. 54, 1537-1549 (2002).
27. D. W. Nelson, H. Cao, Y. Zhu, B. Sunar-Reeder, C. Y. Choi, J. D. Faix, J. M. Brown, A. C. Koong, A. J. Giaccia, and Q. T. Le, "A noninvasive approach for assessing tumor hypoxia in xenografts: Developing a urinary marker for hypoxia," Cancer Res. 65, 6151-6158 (2005).
28. T. Alper and P. Howard-Flanders, "Role of oxygen in modifying the radiosensitivity of E. coli B," Nature (London) 178, 978-979 (1956).
29. K. M. Prise, S. Davies, and B. D. Michael, "Evidence for induction of DNA double-strand breaks at paired radical sites," Radiat. Res. 134, 102-106 (1993).
30. S. J. Whitaker and T. J. McMillan, "Oxygen effect for DNA double-strand break induction determined by pulsed-field gel electrophoresis," Int. J. Radiat. Biol. 61, 29-41 (1992).
31. H. Zhang, C. J. Koch, C. A. Wallen, and K. T. Wheeler, "Radiation-induced DNA damage in tumors and normal tissues. III. Oxygen dependence of the formation of strand breaks and DNA-protein crosslinks," Radiat. Res. 142, 163-168 (1995).
32. R. K. Sachs, P. Hahnfeld, and D. J. Brenner, "The link between low-LET dose-response and the underlying kinetic of damage production/repair/ misrepair," Int. J. Radiat. Biol. 72, 351-374 (1997).
33. J. D. Chapman, "Single-hit mechanism of tumour cell killing by radiation," Int. J. Radiat. Biol. 79, 71-81 (2003).
34. R. K. Sachs and D. J. Brenner, "The mechanistic basis of the linear-quadratic formalism," Med. Phys. 25, 2071-2073 (1998).
35. C. A. Tobias, "The repair-misrepair model in radiobiology: Comparison to other models," Radiat. Res. Suppl. 8, S77-S95 (1985).
36. S. B. Curtis, "Lethal and potentially lethal lesions induced by radiation - A unified repair model," Radiat. Res. 106, 252-270 (1986).
37. L. Hlatky, R. K. Sachs, M. Vazquez, and M. N. Cornforth, "Radiation-induced chromosome aberrations: Insights gained from biophysical modeling," BioEssays 24, 714-723 (2002).
38. M. Guerrero, R. D. Stewart, J. Z. Wang, and X. A. Li, "Equivalence of the linear-quadratic and two-lesion kinetic models," Phys. Med. Biol. 47, 3197-3209 (2002).
39. S. Webb and A. E. Nahum, "A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density," Phys. Med. Biol. 38, 653-666 (1993).
40. W. A. Tomé and J. F. Fowler, "On the inclusion of proliferation in tumour control probability calculations for inhomogeneously irradiated tumours," Phys. Med. Biol. 48, N261-N268 (2003).
41. F. Zölzer and C. Streffer, "Increased radiosensitivity with chronic hypoxia in four human tumor cell lines," Int. J. Radiat. Oncol., Biol., Phys. 54, 910-920 (2002).
42. K. J. Williams, B. A. Telfer, D. Xenaki, M. R. Sheridan, I. Desbaillets, H. I. Peters, D. Honess, A. L. Harris, G. U. Dachs, A. van der Kogel, and I. I. Stratford, "Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1," Radiother. Oncol. 75, 89-98 (2005).
43. R. Hirayama, Y. Furusawa, T. Fukawa, and K. Ando, "Repair kinetics of DNA-DSB induced by x-rays or carbon ions under oxic and hypoxic conditions," J. Radiat. Res. (Tokyo) 46, 325-332 (2005).
44. D. Murray, A. Macann, J. Hanson, and E. Rosenberg, "ERCC1/ERCC4 5′-endonuclease activity as a determinant of hypoxic cell radiosensitivity," Int. J. Radiat. Biol. 69, 319-327 (1996).
45. B. Palcic and L. D. Skarsgard, "Reduced oxygen enhancement ratio at low doses of ionizing radiation," Radiat. Res. 100, 328-339 (1984).
46. T. J. Jenner, C. M. deLara, P. O'Neill, and D. L. Stevens, "Induction and rejoining of DNA double-strand breaks in V79-4 mammalian cells following γ- and α-irradiation," Int. J. Radiat. Biol. 64, 265-273 (1993).
47. O. Sapora, F. Barone, M. Belli, A. Maggi, M. Quintiliani, and M. A. Tabocchini, "Relationships between cell killing, mutation induction and DNA damage in X-irradiated V79 cells: The influence of oxygen and DMSO," Int. J. Radiat. Biol. 60, 467-482 (1991).
48. L. D. Skarsgard and I. Harrison, "Dose dependence of the oxygen enhancement ratio (OER) in radiation inactivation of Chinese hamster V79-171 cells," Radiat. Res. 127, 243-247 (1991).
49. M. E. Watts, R. J. Hodgkiss, N. R. Jones, and J. F. Fowler, "Radiosensitization of Chinese hamster cells by oxygen and misonidazole at low x-ray doses," Int. J. Radiat. Biol. 50, 1009-1021 (1986).
50. I. J. Spiro, C. C. Ling, R. Stickler, and J. Gaskill, "Oxygen radiosensitisation at low dose rate," Br. J. Radiol. 58, 357-363 (1985).
51. C. C. Ling, I. J. Spiro, J. Mitchell, and R. Stickler, "The variation of OER with dose rate," Int. J. Radiat. Oncol., Biol., Phys. 11, 1367-1373 (1985).
52. G. W. Barendsen and H. M. D. Walter, "Effects of different ionizing radiations on human cells in tissue culture," Radiat. Res. 21, 314-329 (1964).
53. G. W. Barendsen, C. J. Koot, G. R. Van Kersen, D. K. Bewley, S. B. Field, and C. J. Parnell, "The effect of oxygen on impairment of the proliferative capacity of human cells in culture by ionizing radiations of different LET," Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 10, 317-327 (1966).
54. K. M. Prise, M. Folkard, S. Davies, and B. D. Michael, "The irradiation of V79 mammalian cells by protons with energies below 2 MeV. II. Measurement of oxygen enhancement ratios and DNA damage," Int. J. Radiat. Biol. 58, 261-277 (1990).
55. B. Efron, "Bootstrap methods: Another look at the jackknife," Ann. Stat. 7, 1-26 (1979).
56. Z. Zheng, "Random weighting methods," Acta Math. Appl. Sin. 10, 247-253 (1987).
57. D. B. Rubin, "The Bayesian bootstrap," Ann. Stat. 9, 130-134 (1981).
58. C. F. J. Wu, "Jackknife, bootstrap and other resampling methods in regression analysis (with discussions)," Ann. Stat. 14, 1261-1350 (1986).
59. A. Gasinska, J. F. Fowler, B. K. Lind, and K. Urbanski, "Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone," Acta Oncol. 43, 657-666 (2004).
60. F. Leborgne, J. F. Fowler, J. H. Leborgne, E. Zubizarreta, and R. Curochquin, "Medium-dose-rate brachytherapy of cancer of the cervix: Preliminary results of a prospectively designed schedule based on the linear-quadratic model," Int. J. Radiat. Oncol., Biol., Phys. 43, 1061-1064 (1999).
61. S. A. Roberts, J. H. Hendry, R. Swindell, J. M. Wilkinson, and R. D. Hunter, "Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: A radiobiological analysis of a randomised clinical trial," Radiother. Oncol. 70, 63-74 (2004).
62. J. Nygren and G. Ahnstrom, "The oxygen effect in permeabilized and histone-depleted cells: An enhanced OER for DNA double-strand breaks, compared to single-strand breaks, is abolished by soluble scavengers," Int. J. Radiat. Biol. 72, 163-170 (1997).
63. F. Darroudi, A. T. Natarajan, G. P. van der Schans, and A. A. van Loon, "Biochemical and cytogenetical characterization of Chinese hamster ovary x-ray-sensitive mutant cells xrs 5 and xrs 6. V. The correlation of DNA strand breaks and base damage to chromosomal aberrations and sister-chromatid exchanges induced by X-irradiation," Mutat. Res. 235, 119-127 (1990).
64. J. S. Prosser, C. M. White, and A. A. Edwards, "The effect of oxygen concentration on the x-ray induction of chromosome aberrations in human lymphocytes," Mutat. Res. 61, 287-295 (1979).
65. B. G. Wouters and J. M. Brown, "Cells at intermediate oxygen levels can be more important than the 'hypoxic fraction' in determining tumor response to fractionated radiotherapy," Radiat. Res. 147, 541-550 (1997).
66. A. Daşu and J. Denekamp, "New insights into factors influencing the clinically relevant oxygen enhancement ratio," Radiother. Oncol. 46, 269-277 (1998).
67. A. Daşu and J. Denekamp, "Superfractionation as a potential hypoxic cell radiosensitizer: Prediction of an optimum dose per fraction," Int. J. Radiat. Oncol., Biol., Phys. 43, 1083-1094 (1999).
68. B. Jones and R. G. Dale, "Mathematical models of tumour and normal tissue response," Acta Oncol. 38, 883-893 (1999).
69. A. E. Nahum, B. Movsas, E. M. Horwitz, C. C. Stobbe, and J. D. Chapman, "Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio," Int. J. Radiat. Oncol., Biol., Phys. 57, 391-401 (2003).
70. C. G. Orton, "In regard to Nahum et al. (Int. J. Radiat. Oncol. Biol. Phys. 53, 391-401 (2003)): Incorporating clinical measurements of hypoxia into tumor control modeling of prostate cancer: Implications for the α/β ratio," Int. J. Radiat. Oncol., Biol., Phys. 58, 1637 (2004).
71. I. Toma-Daşu, "Theoretical modeling of tumour oxygenation and influences on treatment outcome," Ph.D. dissertation, Umeo University, 2004.
72. T. Alper, "The modification of damage caused by primary ionization of biological targets," Radiat. Res. 5, 573-586 (1956).
73. K. Rothkamm and M. Löbrich, "Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses," Proc. Natl. Acad. Sci. U.S.A. 101, 5057-5062 (2003).
74. K. M. Prise, S. Davies, and B. D. Michael, "A comparison of the chemical repair rates of free radical precursors of DNA damage and cell killing in Chinese hamster V79 cells," Int. J. Radiat. Biol. 61, 721-728 (1992).
75. M. Frankenberg-Schwager, D. Frankenberg, R. Harbich, and S. Beckonert, "Evidence against the 'oxygen-in-the-track' hypothesis as an explanation for the radiobiological low oxygen enhancement ratio at high linear energy transfer radiation," Radiat. Environ. Biophys. 33, 1-8 (1994).
76. J. F. Ward, "The complexity of DNA damage: Relevance to biological consequences," Int. J. Radiat. Biol. 66, 427-432 (1994).
77. B. D. Michael and K. M. Prise, "A multiple-radical model for radiation action on DNA and the dependence of OER on LET," Int. J. Radiat. Biol. 69, 351-358 (1996).
78. G. J. Neary, "Chromosome aberrations and the theory of RBE. 1. General considerations," Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 9, 477-502 (1965).
79. T. Alper and P. E. Bryant, "Reduction in oxygen enhancement ratio with increase in LET: Tests of two hypotheses," Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 26, 203-218 (1974).
80. K. F. Baverstock and W. G. Burns, "Primary production of oxygen from irradiated water as an explanation for decreased radiobiological oxygen enhancement at high LET," Nature (London), 260, 316-318 (1976).
81. J. Kiefer, "Theoretical aspects and implications of the oxygen effect," in Radiation Research: Biochemical, Chemical and Physical Perspectives, edited by O. F. Nygaard, H. I. Adler, and W. K. Sinclair (Academic Press, New York, 1975), pp. 1025-1037.
82. Z. Stuglik, "On the Oxygen in heavy-ion tracks' hypothesis," Radiat. Res. 143, 343-348 (1995).
83. U. Amaldi and G. Kraft, "Radiotherapy with beams of carbon ions," Rep. Prog. Phys. 68, 1861-1882 (2005).
84. V. P. Bond, C. V. Robinson, R. Fairchild, and G. Tisljar-Lentulis, "Comparative therapeutic efficacy of high-LET versus low-LET radiations," Natl. Cancer Inst. Monogr. 24, 23-43 (1967).
85. G. P. van der Schans, H. B. Centen, and P. H. M. Lohman, "DNA Lesions Induced by Ionizing Radiation," in Progress in Mutation Research Vol. 4, edited by A. T. Natarajan, G. Obe, and H. Altmann (Elsevier, Amsterdam, 1982), pp. 285-299.
86. O. Vos, G. P. van der Schans, and W. S. Roos-Verheij, "Reduction of intracellular glutathione content and radiosensitivity," Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 50, 155-165 (1986).
87. M. Frankenberg-Schwager, D. Frankenberg, and R. Harbich, "Different oxygen enhancement ratios for induced and unrejoined DNA double-strand breaks in eukaryotic cells," Radiat. Res. 128, 243-250 (1991).
88. M. Frankenburg-Schwager, R. Harbich, S. Beckonert, and D. Frankenberg, "Half-life values for DNA double-strand break rejoining in yeast can vary by more than an order of magnitude depending on the irradiation conditions," Int. J. Radiat. Biol. 66, 543-547 (1994).
89. G. G. Steel, "From targets to genes: A brief history of radiosensitivity," Phys. Med. Biol. 41, 205-222 (1996).
90. E. M. Rosen, S. Fan, S. Rockwell, and I. D. Goldberg, "The molecular and cellular basis of radiosensitivity: Implications for understanding how normal tissues and tumors respond to therapeutic radiation," Cancer Invest. 17, 56-72 (1999).
91. A. S. Ljungkvist, J. Bussink, J. H. Kaanders, P. F. Rijken, A. C. Begg, J. A. Raleigh, and A. J. van der Kogel, "Hypoxic cell turnover in different solid tumor lines," Int. J. Radiat. Oncol., Biol., Phys. 62, 1157-1168 (2005).
92. K. W. Kinzler and B. Vogelstein, "Life (and death) in a malignant tumour," Nature (London) 379, 19-20 (1996).
93. T. Tokino and Y. Nakamura, "The role of p53-target genes in human cancer," Crit. Rev. Oncol. Hematol. 33, 1-6 (2000).
94. X. A. Li, J. Z. Wang, R. D. Stewart, and S. J. DiBiase, "Dose escalation in permanent brachytherapy for prostate cancer: Dosimetric and biological considerations," Phys. Med. Biol. 48, 2753-2765 (2003).
95. R. A. Popple, R. Ove, and S. Shen, "Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation," Int. J. Radiat. Oncol., Biol., Phys. 54, 921-927 (2002).